Indian consumer wellness company selling sugar-substitutes, health drinks and skincare brands like Sugar Free, Complan and Nycil.
Indian consumer wellness company selling sugar-substitutes, health drinks and skincare brands like Sugar Free, Complan and Nycil.
Grew by buying brands: Complan, Glucon-D and Nycil came with the 2019 purchase of Heinz's Indian consumer business, while Sugar Free was already its own. The Zydus group is the controlling shareholder, and summer-season drinks like Glucon-D make earnings seasonal.
In one line: India's smaller Church & Dwight for health/wellness brands.
Moat: narrow (brand, distribution). Long-established household brand names in niche wellness categories with strong retail distribution.
Headquarters: Ahmedabad, India · Founded: 1988 · Employees: 3,789
Size Zydus Wellness (ZYDUSWELL.NS) is an India Consumer Staples company (Food: Major Diversified) with a market value of $1.55B, the 462nd largest of 1,066 India companies the cockpit tracks. Shares closed at ₹456.60 on 18 Nov 2026.
Performance Over six months the shares fell 10.3%, against -7.2% for the median peer and +3.8% for the India market (cap-weighted) — 9th lowest of 21 in its peer set.
Growth Revenue grew 73.7% over the last twelve months (peer median +3.5%); the operating margin is 8.5% (peer median 8.1%).
Valuation It trades at 47.7× forward earnings against a peer median of 16.0× (2nd most expensive of 15).
Price implies For today's price to make sense, revenue must grow about 32% a year for seven years (Req g). Recent delivered growth is +16%, so the hurdle is +16 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
Capital Return on invested capital runs 6.4 points below its cost of capital (10.0% WACC).
Next results Next results expected around 14 Feb 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | ₹50.1B | ₹39.5B | ₹27.1B | ₹23.3B | ₹22.5B |
| Revenue growth | — | +46% | +16% | +3% | — |
| Gross profit | ₹26.2B | ₹18.2B | ₹10.8B | ₹8.87B | ₹8.38B |
| EBITDA | ₹6.53B | ₹4.94B | ₹3.80B | ₹3.08B | ₹3.38B |
| Net income | ₹2.46B | ₹1.97B | ₹3.47B | ₹2.67B | ₹3.10B |
| Free cash flow | n/a | ₹393M | ₹3.03B | ₹2.05B | ₹340M |
| Capital expenditure | n/a | ₹1.02B | ₹663M | ₹285M | ₹450M |
| Total debt | ₹31.7B | ₹32.0B | ₹1.88B | ₹3.29B | ₹2.97B |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| Zydus Wellness ZYDUSWELL.NS | $1.55B | -10% | +74% | 9% | 47.7× | 32.1% |
| Nestle India NESTLEIND.NS | $26.5B | -10% | +22% | 21% | 59.4× | 36.9% |
| Hindustan Unilever HINDUNILVR.NS | $50.0B | -11% | +6% | 21% | 41.4× | 27.4% |
| Dabur India DABUR.NS | $7.16B | -16% | +9% | 15% | 31.8× | 27.4% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | ZYDUSWELL.NS | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -11.4% | -3.8% | 5th lowest of 21 |
| 6-month return | -10.3% | -7.2% | 9th lowest of 21 |
| Distance from 52-week high | -25.4% | -21.3% | 9th lowest of 21 |
| Revenue growth (TTM) | +73.7% | +3.5% | highest of 21 |
| Operating margin | 8.5% | 8.1% | 11th highest of 21 |
| Forward P/E | 47.7× | 16.0× | 2nd most expensive of 15 |
| Growth the price implies (Req g, 7 yrs) | 32.1% | -3.9% | most demanding of 16 |
| Growth delivered (Del g) | +16.2% | +2.5% | 3rd highest of 16 |
| Hurdle (Req g minus delivered) | +15.9 pp | -4.8 pp | 3rd most demanding of 16 |
| ROIC minus cost of capital | -6.4 pp | +3.8 pp | 2nd lowest of 21 |
| EV / EBITDA | 26.7× | 8.6× | 2nd most expensive of 12 |
| Net debt / EBITDA | 4.5× | 0.0× | 3rd most indebted of 14 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Zydus Wellness ZYDUSWELL.NS | India | $1.55B | -10% | +74% | 9% | 47.7× | 32.1% | +16.2% |
| Yankershop Food 002847.SZ | China | $1.56B | -31% | 0% | 14% | 13.9× | 2.3% | +24.1% |
| Herbalife HLF | United States | $1.68B | +28% | +6% | 9% | 5.7× | -14.2% | -1.9% |
| Cheng De Lolo 000848.SZ | China | $1.24B | -8% | +5% | 24% | 13.3× | -9.6% | +11.3% |
| Dongsuh 026960.KS | South Korea | $2.11B | +5% | -1% | 7% | n/a | 18.4% | +1.6% |
| S&B Foods 2805.T | Japan | $1.14B | +42% | +7% | 9% | 16.7× | -2.3% | +2.5% |
| Yihai International 1579.HK | Hong Kong | $2.12B | +12% | +11% | 18% | 14.9× | 8.1% | +3.6% |
| ITO EN,Ltd 2593.T | Japan | $2.15B | +16% | +5% | 5% | 26.8× | n/a | n/a |
| Jiangsu Hengshun Vinegar-Industry 600305.SS | China | $1.12B | -7% | +6% | 6% | 48.9× | 17.1% | +2.6% |
| Simply Good Foods SMPL | United States | $1.10B | +13% | -7% | 13% | 8.3× | -11.2% | +6.2% |
| Olam VC2.SI | Singapore | $2.38B | -31% | -40% | 2% | 16.6× | -3.9% | -3.7% |
| Bombay Burmah Trading BBTC.NS | India | $985M | -14% | +10% | 16% | n/a | -5.8% | +8.2% |
| Shanghai Ziyan Foods 603057.SS | China | $981M | -44% | +7% | 6% | 35.3× | n/a | n/a |
| Chagee Holdings Limited Unsponsored ADR CHA | United States | $2.61B | +33% | 0% | 11% | 8.5× | -2.1% | +190.8% |
| Vitasoy International 0345.HK | Hong Kong | $807M | -1% | -3% | 7% | 22.1× | -9.0% | -4.2% |
| AGT Food and Ingredients AGTF.TO | Canada | $804M | 0% | -17% | -2% | 15.3× | n/a | n/a |
| Hongmian Zhihui Science and Technology Innovation Co., Ltd. Guangzhou 000523.SZ | China | $743M | -20% | +4% | 2% | n/a | 10.8% | -8.5% |
| V V Food & Beverage 600300.SS | China | $726M | -11% | +6% | 11% | n/a | -8.8% | -6.8% |
| Lian Hwa Foods 1231.TW | Taiwan | $707M | -10% | +1% | 9% | n/a | n/a | n/a |
| Standard Foods 1227.TW | Taiwan | $687M | -12% | +3% | 4% | n/a | n/a | n/a |
| Xiangpiaopiao Food 603711.SS | China | $642M | -31% | +2% | 7% | 19.7× | -12.0% | -4.9% |